Infertility
Conditions
Brief summary
The primary outcome is conception leading to live birth, with a positive pregnancy test preceding the pregnancy within 6 months after randomization.
Detailed description
Biochemical pregnancy, Clinical pregnancy, Ongoing pregnancy, Miscarriage, Ectopic pregnancy, Multiple pregnancy, Time to pregnancy, Complications following HSG (infection, intravastion), Pregnancy outcomes (f.e. birth weight), Pregnancy complications, Stillbirth, Thyroid function of the woman (before and 1 month after HSG), Neonatal outcomes, Additional fertility treatments (Intra-uterine insemination, IVF, IVF/ICSI), Costs within 6 months after randomization, Thyroid function of neonate (determined by heelprick)
Interventions
DRUGVISIPAQUE 320 mg I/ml
DRUGoplossing voor injectie
DRUGLipiodol Ultra Fluide
DRUG480 mg I/ml
DRUGoplossing voor injectie.
Sponsors
Amsterdam UMC Stichting
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is conception leading to live birth, with a positive pregnancy test preceding the pregnancy within 6 months after randomization. | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical pregnancy, Clinical pregnancy, Ongoing pregnancy, Miscarriage, Ectopic pregnancy, Multiple pregnancy, Time to pregnancy, Complications following HSG (infection, intravastion), Pregnancy outcomes (f.e. birth weight), Pregnancy complications, Stillbirth, Thyroid function of the woman (before and 1 month after HSG), Neonatal outcomes, Additional fertility treatments (Intra-uterine insemination, IVF, IVF/ICSI), Costs within 6 months after randomization, Thyroid function of neonate (determined by heelprick) | — |
Countries
Netherlands
Outcome results
None listed